Arlet Alarcon

This inventor holds 11 USPTO granted patents and 30 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Caris Mpi, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arlet Alarcon. Retrieved from https://idiyas.com/inventor/arlet-alarcon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 30)

% Patents Active = 81.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 8.0

ph-index = 6

Forward Citations = 105(Granted Patents)

Company Filing History:

11 out of 22

Caris Mpi, Inc.

patents

Years Active: 2014-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12754193 - Molecular profiling of tumors (2026-10-06),

2. 12687554 - Molecular profiling of tumors (2026-07-21),

3. 12366585 - Molecular profiling of tumors (2025-07-22),

4. 9389234 - Molecular profiling of tumors (2016-07-12),

5. 9322067 - Molecular profiling of tumors (2016-04-26),

6. 9292660 - Molecular profiling of tumors (2016-03-22),

7. 9092392 - Molecular profiling of tumors (2015-07-28),

8. 9064045 - Molecular profiling of tumors (2015-06-23),

9. 9058418 - Molecular profiling of tumors (2015-06-16),

10. 9053224 - Molecular profiling of tumors (2015-06-09),

11. 8768629 - Molecular profiling of tumors (2014-07-01),

Title: The Innovative Contributions of Arlet Alarcon in Molecular Profiling

Introduction

Arlet Alarcon, based in Phoenix, AZ, is an accomplished inventor known for her significant contributions to the field of molecular profiling, particularly in cancer research. With a remarkable portfolio of 9 patents, she continues to push the boundaries of medical innovation.

Latest Patents

Among her latest inventions is a groundbreaking patent focused on the "Molecular Profiling of Tumors." This invention outlines novel methods and systems for molecular profiling of diseases, such as cancer. It provides an innovative approach to identify treatments for diseases, including those that may not have been initially recognized as effective or expected treatments. This work is pivotal in enhancing treatment efficacy and personalizing healthcare.

Career Highlights

Arlet Alarcon is currently associated with Caris MPI, Inc., where she leverages her expertise to advance research and development in cancer diagnostics. Her role at the company enables her to collaborate with other leading experts in the field, contributing to significant advancements in medical technology.

Collaborations

Throughout her career, Arlet has collaborated with notable colleagues, including Daniel D. Von Hoff and David M. Loesch. These partnerships have fostered a collaborative environment focused on innovation and excellence in cancer research, amplifying the impact of her inventions.

Conclusion

Arlet Alarcon's dedication to innovation in molecular profiling not only showcases her talent as an inventor but also highlights the importance of her work in the fight against cancer. Her contributions continue to pave the way for new therapeutic strategies and improved patient outcomes in the medical community.

Profile summary based on public USPTO records.